Fuchigami Takao, Ono Yusuke, Kishida Shosei, Nakamura Norifumi
Department of Oral and Maxillofacial Surgery, Field of Maxillofacial Rehabilitation Graduate School of Medical and Dental Sciences, Kagoshima University, Japan.
Department of Biochemistry and Genetics, Kagoshima University Graduate School of Medical and Dental Sciences, Kagoshima University, Japan.
Jpn Dent Sci Rev. 2021 Nov;57:27-32. doi: 10.1016/j.jdsr.2020.12.003. Epub 2021 Feb 24.
Ameloblastoma is benign odontogenic tumours that mainly occur in the jawbone. This tumour induces aggressive invasion into the surrounding bone and has a high recurrence rate after surgery. Therefore, mandibular resection is performed in many patients with this tumour, causing aesthetic and functional problems. It is necessary to develop a novel treatment strategy for ameloblastoma, but there are currently no innovative treatments. Although our understanding of the molecular biological mechanisms of ameloblastoma is still insufficient, there have been many recent reports of new molecular biological findings on ameloblastoma. Therefore, bioactive factors that have potential for novel therapeutic methods, such as molecular targeted therapy, have been discovered in ameloblastoma. In this review, we summarize the molecular biological findings of ameloblastoma reported over several decades, focusing on factors involved in invasion into surrounding tissues and disease-specific gene mutations. We also mention the effect of the interaction between tumour cells and stromal components in ameloblastoma on tumour development. Oral surgery, Odontogenic tumor, Ameloblastoma.
成釉细胞瘤是主要发生于颌骨的良性牙源性肿瘤。该肿瘤可侵袭周围骨质,术后复发率高。因此,许多成釉细胞瘤患者需行下颌骨切除术,这会导致美观和功能问题。有必要开发一种新的成釉细胞瘤治疗策略,但目前尚无创新性治疗方法。尽管我们对成釉细胞瘤的分子生物学机制仍了解不足,但近期有许多关于成釉细胞瘤新分子生物学发现的报道。因此,在成釉细胞瘤中已发现了具有新型治疗方法潜力的生物活性因子,如分子靶向治疗。在本综述中,我们总结了几十年来报道的成釉细胞瘤分子生物学发现,重点关注参与侵袭周围组织的因子和疾病特异性基因突变。我们还提及了成釉细胞瘤中肿瘤细胞与基质成分之间的相互作用对肿瘤发展的影响。口腔外科手术、牙源性肿瘤、成釉细胞瘤。